APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cancer Treatment Drugs

Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.

Selected research

Market Structure

Global Cancer Treatment Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173974420321 December 2025192 pages

Choose your research edition.

Industry ResearchCancer Treatment Drugs Industry Research Report 2026151 pages · $2,950 USDIndustry Growth & TrendsGlobal Cancer Treatment Drugs Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Cancer Treatment Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cancer Treatment Drugs Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Cancer Treatment Drugs Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.

Global Cancer Treatment Drugs key players include Roche, Novartis, Celgene, Bristol-Myers Squibb, etc.

North America is the largest market, with a share over 40%, followed by China, and Europe, both have a share over 30 percent.

Read the full market overview

In terms of product, Chemotherapy is the largest segment, with a share about 50%. And in terms of application, the largest application is Blood Cancer, followed by Breast Cancer, Prostate Cancer, Respiratory or Lung Cancer, etc.

This report provides an overview of the global Cancer Treatment Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cancer Treatment Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cancer Treatment Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cancer Treatment Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Cancer Treatment Drugs Segment by Company

Roche

Novartis

Celgene

Bristol-Myers Squibb

Amgen

Johnson & Johnson

Pfizer

Takeda

Eli Lilly

AstraZeneca

Astellas

Merck & Co.

Sanofi

Bayer

Biogen Idec

Eisai

Teva

Otsuka

Merck KGaA

Ipsen

AbbVie

Gilead Sciences

Cancer Treatment Drugs Segment by Type

Chemotherapy

Targeted Therapy

Immunotherapy

Hormonal Therapy (Biologic Therapy)

Others

Cancer Treatment Drugs Segment by Application

Blood Cancer

Breast Cancer

Gastrointestinal Cancer

Prostate Cancer

Respiratory or Lung Cancer

Others

Cancer Treatment Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cancer Treatment Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cancer Treatment Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cancer Treatment Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cancer Treatment Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cancer Treatment Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Cancer Treatment Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Cancer Treatment Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Cancer Treatment Drugs Industry Trends Table 2. Cancer Treatment Drugs Industry Drivers Table 3. Cancer Treatment Drugs Industry Opportunities and Challenges Table 4. Cancer Treatment Drugs Industry Restraints Table 5. Global Cancer Treatment Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Cancer Treatment Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Cancer Treatment Drugs Sales by Manufacturers (K Pcs) & (2021-2026) Table 8. Global Cancer Treatment Drugs Sales Market Share by Manufacturers Table 9. Global Cancer Treatment Drugs Average Sales Price (USD/Pcs) of Manufacturers (2021-2026) Table 10. Global Cancer Treatment Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Cancer Treatment Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Cancer Treatment Drugs Manufacturers, Product Type & Application Table 13. Global Cancer Treatment Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Cancer Treatment Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Chemotherapy Table 17. Major Manufacturers of Targeted Therapy Table 18. Major Manufacturers of Immunotherapy Table 19. Major Manufacturers of Hormonal Therapy (Biologic Therapy) Table 20. Major Manufacturers of Others Table 21. Global Cancer Treatment Drugs Sales by Type 2021 VS 2025 VS 2032 (K Pcs) Table 22. Global Cancer Treatment Drugs Sales by Type (2021-2026) & (K Pcs) Table 23. Global Cancer Treatment Drugs Sales by Type (2027-2032) & (K Pcs) Table 24. Global Cancer Treatment Drugs Sales Market Share by Type (2021-2026) Table 25. Global Cancer Treatment Drugs Sales Market Share by Type (2027-2032) Table 26. Global Cancer Treatment Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Pcs) Table 27. Global Cancer Treatment Drugs Revenue by Type (2021-2026) & (K Pcs) Table 28. Global Cancer Treatment Drugs Revenue by Type (2027-2032) & (K Pcs) Table 29. Global Cancer Treatment Drugs Revenue Market Share by Type (2021-2026) Table 30. Global Cancer Treatment Drugs Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Blood Cancer Table 32. Major Manufacturers of Breast Cancer Table 33. Major Manufacturers of Gastrointestinal Cancer Table 34. Major Manufacturers of Prostate Cancer Table 35. Major Manufacturers of Respiratory or Lung Cancer Table 36. Major Manufacturers of Others Table 37. Global Cancer Treatment Drugs Sales by Application 2021 VS 2025 VS 2032 (K Pcs) Table 38. Global Cancer Treatment Drugs Sales by Application (2021-2026) & (K Pcs) Table 39. Global Cancer Treatment Drugs Sales by Application (2027-2032) & (K Pcs) Table 40. Global Cancer Treatment Drugs Sales Market Share by Application (2021-2026) Table 41. Global Cancer Treatment Drugs Sales Market Share by Application (2027-2032) Table 42. Global Cancer Treatment Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Pcs) Table 43. Global Cancer Treatment Drugs Revenue by Application (2021-2026) & (K Pcs) Table 44. Global Cancer Treatment Drugs Revenue by Application (2027-2032) & (K Pcs) Table 45. Global Cancer Treatment Drugs Revenue Market Share by Application (2021-2026) Table 46. Global Cancer Treatment Drugs Revenue Market Share by Application (2027-2032) Table 47. Global Cancer Treatment Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Pcs) Table 48. Global Cancer Treatment Drugs Sales by Region (2021-2026) & (K Pcs) Table 49. Global Cancer Treatment Drugs Sales Market Share by Region (2021-2026) Table 50. Global Cancer Treatment Drugs Sales Forecasted by Region (2027-2032) & (K Pcs) Table 51. Global Cancer Treatment Drugs Sales Forecasted Market Share by Region (2027-2032) Table 52. North America Cancer Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 53. North America Cancer Treatment Drugs Sales by Country (2021-2026) & (K Pcs) Table 54. North America Cancer Treatment Drugs Sales by Country (2027-2032) & (K Pcs) Table 55. Europe Cancer Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 56. Europe Cancer Treatment Drugs Sales by Country (2021-2026) & (K Pcs) Table 57. Europe Cancer Treatment Drugs Sales by Country (2027-2032) & (K Pcs) Table 58. Asia Pacific Cancer Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 59. Asia Pacific Cancer Treatment Drugs Sales by Country (2021-2026) & (K Pcs) Table 60. Asia Pacific Cancer Treatment Drugs Sales by Country (2027-2032) & (K Pcs) Table 61. South America, Middle East and Africa Cancer Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 62. South America, Middle East and Africa Cancer Treatment Drugs Sales by Country (2021-2026) & (K Pcs) Table 63. South America, Middle East and Africa Cancer Treatment Drugs Sales by Country (2027-2032) & (K Pcs) Table 64. Global Cancer Treatment Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 65. Global Cancer Treatment Drugs Revenue by Region (2021-2026) & (US$ Million) Table 66. Global Cancer Treatment Drugs Revenue by Region (2027-2032) & (US$ Million) Table 67. Global Cancer Treatment Drugs Revenue Market Share by Region (2021-2026) Table 68. Global Cancer Treatment Drugs Revenue Market Share by Region (2027-2032) Table 69. Roche Company Information Table 70. Roche Business Overview Table 71. Roche Cancer Treatment Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Roche Cancer Treatment Drugs Product Portfolio Table 73. Roche Recent Development Table 74. Novartis Company Information Table 75. Novartis Business Overview Table 76. Novartis Cancer Treatment Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Novartis Cancer Treatment Drugs Product Portfolio Table 78. Novartis Recent Development Table 79. Celgene Company Information Table 80. Celgene Business Overview Table 81. Celgene Cancer Treatment Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Celgene Cancer Treatment Drugs Product Portfolio Table 83. Celgene Recent Development Table 84. Bristol-Myers Squibb Company Information Table 85. Bristol-Myers Squibb Business Overview Table 86. Bristol-Myers Squibb Cancer Treatment Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Bristol-Myers Squibb Cancer Treatment Drugs Product Portfolio Table 88. Bristol-Myers Squibb Recent Development Table 89. Amgen Company Information Table 90. Amgen Business Overview Table 91. Amgen Cancer Treatment Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Amgen Cancer Treatment Drugs Product Portfolio Table 93. Amgen Recent Development Table 94. Johnson & Johnson Company Information Table 95. Johnson & Johnson Business Overview Table 96. Johnson & Johnson Cancer Treatment Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Johnson & Johnson Cancer Treatment Drugs Product Portfolio Table 98. Johnson & Johnson Recent Development Table 99. Pfizer Company Information Table 100. Pfizer Business Overview Table 101. Pfizer Cancer Treatment Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Pfizer Cancer Treatment Drugs Product Portfolio Table 103. Pfizer Recent Development Table 104. Takeda Company Information Table 105. Takeda Business Overview Table 106. Takeda Cancer Treatment Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Takeda Cancer Treatment Drugs Product Portfolio Table 108. Takeda Recent Development Table 109. Eli Lilly Company Information Table 110. Eli Lilly Business Overview Table 111. Eli Lilly Cancer Treatment Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Eli Lilly Cancer Treatment Drugs Product Portfolio Table 113. Eli Lilly Recent Development Table 114. AstraZeneca Company Information Table 115. AstraZeneca Business Overview Table 116. AstraZeneca Cancer Treatment Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. AstraZeneca Cancer Treatment Drugs Product Portfolio Table 118. AstraZeneca Recent Development Table 119. Astellas Company Information Table 120. Astellas Business Overview Table 121. Astellas Cancer Treatment Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Astellas Cancer Treatment Drugs Product Portfolio Table 123. Astellas Recent Development Table 124. Merck & Co. Company Information Table 125. Merck & Co. Business Overview Table 126. Merck & Co. Cancer Treatment Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Merck & Co. Cancer Treatment Drugs Product Portfolio Table 128. Merck & Co. Recent Development Table 129. Sanofi Company Information Table 130. Sanofi Business Overview Table 131. Sanofi Cancer Treatment Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Sanofi Cancer Treatment Drugs Product Portfolio Table 133. Sanofi Recent Development Table 134. Bayer Company Information Table 135. Bayer Business Overview Table 136. Bayer Cancer Treatment Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Bayer Cancer Treatment Drugs Product Portfolio Table 138. Bayer Recent Development Table 139. Biogen Idec Company Information Table 140. Biogen Idec Business Overview Table 141. Biogen Idec Cancer Treatment Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Biogen Idec Cancer Treatment Drugs Product Portfolio Table 143. Biogen Idec Recent Development Table 144. Eisai Company Information Table 145. Eisai Business Overview Table 146. Eisai Cancer Treatment Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. Eisai Cancer Treatment Drugs Product Portfolio Table 148. Eisai Recent Development Table 149. Teva Company Information Table 150. Teva Business Overview Table 151. Teva Cancer Treatment Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 152. Teva Cancer Treatment Drugs Product Portfolio Table 153. Teva Recent Development Table 154. Otsuka Company Information Table 155. Otsuka Business Overview Table 156. Otsuka Cancer Treatment Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 157. Otsuka Cancer Treatment Drugs Product Portfolio Table 158. Otsuka Recent Development Table 159. Merck KGaA Company Information Table 160. Merck KGaA Business Overview Table 161. Merck KGaA Cancer Treatment Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 162. Merck KGaA Cancer Treatment Drugs Product Portfolio Table 163. Merck KGaA Recent Development Table 164. Ipsen Company Information Table 165. Ipsen Business Overview Table 166. Ipsen Cancer Treatment Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 167. Ipsen Cancer Treatment Drugs Product Portfolio Table 168. Ipsen Recent Development Table 169. AbbVie Company Information Table 170. AbbVie Business Overview Table 171. AbbVie Cancer Treatment Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 172. AbbVie Cancer Treatment Drugs Product Portfolio Table 173. AbbVie Recent Development Table 174. Gilead Sciences Company Information Table 175. Gilead Sciences Business Overview Table 176. Gilead Sciences Cancer Treatment Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 177. Gilead Sciences Cancer Treatment Drugs Product Portfolio Table 178. Gilead Sciences Recent Development Table 179. Key Raw Materials Table 180. Raw Materials Key Suppliers Table 181. Cancer Treatment Drugs Distributors List Table 182. Cancer Treatment Drugs Customers List Table 183. Research Programs/Design for This Report Table 184. Authors List of This Report Table 185. Secondary Sources Table 186. Primary Sources List of Figures Figure 1. Cancer Treatment Drugs Product Image Figure 2. Global Cancer Treatment Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cancer Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Cancer Treatment Drugs Sales (2021-2032) & (K Pcs) Figure 5. Global Cancer Treatment Drugs Average Price (USD/Pcs) & (2021-2032) Figure 6. Global Top 5 and 10 Cancer Treatment Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Chemotherapy Image Figure 9. Targeted Therapy Image Figure 10. Immunotherapy Image Figure 11. Hormonal Therapy (Biologic Therapy) Image Figure 12. Others Image Figure 13. Global Cancer Treatment Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Pcs) Figure 14. Global Cancer Treatment Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Cancer Treatment Drugs Sales Market Share by Type (2021-2032) Figure 16. Global Cancer Treatment Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Pcs) Figure 17. Global Cancer Treatment Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Cancer Treatment Drugs Revenue Market Share by Type (2021-2032) Figure 19. Blood Cancer Image Figure 20. Breast Cancer Image Figure 21. Gastrointestinal Cancer Image Figure 22. Prostate Cancer Image Figure 23. Respiratory or Lung Cancer Image Figure 24. Others Image Figure 25. Global Cancer Treatment Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Pcs) Figure 26. Global Cancer Treatment Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 27. Global Cancer Treatment Drugs Sales Market Share by Application (2021-2032) Figure 28. Global Cancer Treatment Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Pcs) Figure 29. Global Cancer Treatment Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 30. Global Cancer Treatment Drugs Revenue Market Share by Application (2021-2032) Figure 31. North America Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Pcs) Figure 32. North America Cancer Treatment Drugs Sales Market Share by Country (2021-2032) Figure 33. U.S. Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Pcs) Figure 34. Canada Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Pcs) Figure 35. Mexico Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Pcs) Figure 36. Europe Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Pcs) Figure 37. Europe Cancer Treatment Drugs Sales Market Share by Country (2021-2032) Figure 38. Germany Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Pcs) Figure 39. France Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Pcs) Figure 40. U.K. Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Pcs) Figure 41. Italy Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Pcs) Figure 42. Netherlands Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Pcs) Figure 43. Asia Pacific Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Pcs) Figure 44. Asia Pacific Cancer Treatment Drugs Sales Market Share by Country (2021-2032) Figure 45. China Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Pcs) Figure 46. Japan Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Pcs) Figure 47. South Korea Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Pcs) Figure 48. Southeast Asia Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Pcs) Figure 49. India Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Pcs) Figure 50. Australia Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Pcs) Figure 51. South America, Middle East and Africa Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Pcs) Figure 52. South America, Middle East and Africa Cancer Treatment Drugs Sales Market Share by Country (2021-2032) Figure 53. Brazil Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Pcs) Figure 54. South Africa Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Pcs) Figure 55. Saudi Arabia Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Pcs) Figure 56. Turkey Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Pcs) Figure 57. Argentina Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Pcs) Figure 58. UAE Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Pcs) Figure 59. Egypt Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Pcs) Figure 60. Chile Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Pcs) Figure 61. Global Cancer Treatment Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Global Cancer Treatment Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 63. North America Cancer Treatment Drugs Revenue (2021-2032) & (US$ Million) Figure 64. North America Cancer Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Europe Cancer Treatment Drugs Revenue (2021-2032) & (US$ Million) Figure 66. Europe Cancer Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Asia-Pacific Cancer Treatment Drugs Revenue (2021-2032) & (US$ Million) Figure 68. Asia-Pacific Cancer Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. South America, Middle East and Africa Cancer Treatment Drugs Revenue (2021-2032) & (US$ Million) Figure 70. South America, Middle East and Africa Cancer Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 71. Cancer Treatment Drugs Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Cancer Treatment Drugs Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Chemotherapy
  • Targeted Therapy
  • Immunotherapy
  • Hormonal Therapy (Biologic Therapy)
  • Others
Applications
  • Blood Cancer
  • Breast Cancer
  • Gastrointestinal Cancer
  • Prostate Cancer
  • Respiratory or Lung Cancer
  • Others
Companies covered
  • Roche
  • Novartis
  • Celgene
  • Bristol-Myers Squibb
  • Amgen
  • Johnson & Johnson
  • Pfizer
  • Takeda
  • Eli Lilly
  • AstraZeneca
  • Astellas
  • Merck & Co.
  • Sanofi
  • Bayer
  • Biogen Idec
  • Eisai
  • Teva
  • Otsuka
  • Merck KGaA
  • Ipsen
  • AbbVie
  • Gilead Sciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cancer Treatment Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cancer Treatment Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Cancer Treatment Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Cancer Treatment Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Cancer Treatment Drugs Market Dynamics
  1. 2.1 Cancer Treatment Drugs Industry Trends
  2. 2.2 Cancer Treatment Drugs Industry Drivers
  3. 2.3 Cancer Treatment Drugs Industry Opportunities and Challenges
  4. 2.4 Cancer Treatment Drugs Industry Restraints
3 Cancer Treatment Drugs Market by Manufacturers
  1. 3.1 Global Cancer Treatment Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Cancer Treatment Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Cancer Treatment Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Cancer Treatment Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cancer Treatment Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Cancer Treatment Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Cancer Treatment Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cancer Treatment Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cancer Treatment Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cancer Treatment Drugs Tier 1, Tier 2, and Tier 3
4 Cancer Treatment Drugs Market by Type
  1. 4.1 Cancer Treatment Drugs Type Introduction
  2. 4.1.1 Chemotherapy
  3. 4.1.2 Targeted Therapy
  4. 4.1.3 Immunotherapy
  5. 4.1.4 Hormonal Therapy (Biologic Therapy)
  6. 4.1.5 Others
  7. 4.2 Global Cancer Treatment Drugs Sales by Type
  8. 4.2.1 Global Cancer Treatment Drugs Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Cancer Treatment Drugs Sales by Type (2021-2032)
  10. 4.2.3 Global Cancer Treatment Drugs Sales Market Share by Type (2021-2032)
  11. 4.3 Global Cancer Treatment Drugs Revenue by Type
  12. 4.3.1 Global Cancer Treatment Drugs Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Cancer Treatment Drugs Revenue by Type (2021-2032)
  14. 4.3.3 Global Cancer Treatment Drugs Revenue Market Share by Type (2021-2032)
5 Cancer Treatment Drugs Market by Application
  1. 5.1 Cancer Treatment Drugs Application Introduction
  2. 5.1.1 Blood Cancer
  3. 5.1.2 Breast Cancer
  4. 5.1.3 Gastrointestinal Cancer
  5. 5.1.4 Prostate Cancer
  6. 5.1.5 Respiratory or Lung Cancer
  7. 5.1.6 Others
  8. 5.2 Global Cancer Treatment Drugs Sales by Application
  9. 5.2.1 Global Cancer Treatment Drugs Sales by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Cancer Treatment Drugs Sales by Application (2021-2032)
  11. 5.2.3 Global Cancer Treatment Drugs Sales Market Share by Application (2021-2032)
  12. 5.3 Global Cancer Treatment Drugs Revenue by Application
  13. 5.3.1 Global Cancer Treatment Drugs Revenue by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Cancer Treatment Drugs Revenue by Application (2021-2032)
  15. 5.3.3 Global Cancer Treatment Drugs Revenue Market Share by Application (2021-2032)
6 Global Cancer Treatment Drugs Sales by Region
  1. 6.1 Global Cancer Treatment Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cancer Treatment Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Cancer Treatment Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Cancer Treatment Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cancer Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Cancer Treatment Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Cancer Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Cancer Treatment Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Cancer Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Cancer Treatment Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Cancer Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Cancer Treatment Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Cancer Treatment Drugs Revenue by Region
  1. 7.1 Global Cancer Treatment Drugs Revenue by Region
  2. 7.1.1 Global Cancer Treatment Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Cancer Treatment Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Cancer Treatment Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Cancer Treatment Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Cancer Treatment Drugs Revenue (2021-2032)
  8. 7.2.2 North America Cancer Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Cancer Treatment Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Cancer Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Cancer Treatment Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Cancer Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Cancer Treatment Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Cancer Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Roche
  2. 8.1.1 Roche Company Information
  3. 8.1.2 Roche Business Overview
  4. 8.1.3 Roche Cancer Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Roche Cancer Treatment Drugs Product Portfolio
  6. 8.1.5 Roche Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Cancer Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Cancer Treatment Drugs Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 Celgene
  14. 8.3.1 Celgene Company Information
  15. 8.3.2 Celgene Business Overview
  16. 8.3.3 Celgene Cancer Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Celgene Cancer Treatment Drugs Product Portfolio
  18. 8.3.5 Celgene Recent Developments
  19. 8.4 Bristol-Myers Squibb
  20. 8.4.1 Bristol-Myers Squibb Company Information
  21. 8.4.2 Bristol-Myers Squibb Business Overview
  22. 8.4.3 Bristol-Myers Squibb Cancer Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bristol-Myers Squibb Cancer Treatment Drugs Product Portfolio
  24. 8.4.5 Bristol-Myers Squibb Recent Developments
  25. 8.5 Amgen
  26. 8.5.1 Amgen Company Information
  27. 8.5.2 Amgen Business Overview
  28. 8.5.3 Amgen Cancer Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Amgen Cancer Treatment Drugs Product Portfolio
  30. 8.5.5 Amgen Recent Developments
  31. 8.6 Johnson & Johnson
  32. 8.6.1 Johnson & Johnson Company Information
  33. 8.6.2 Johnson & Johnson Business Overview
  34. 8.6.3 Johnson & Johnson Cancer Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Johnson & Johnson Cancer Treatment Drugs Product Portfolio
  36. 8.6.5 Johnson & Johnson Recent Developments
  37. 8.7 Pfizer
  38. 8.7.1 Pfizer Company Information
  39. 8.7.2 Pfizer Business Overview
  40. 8.7.3 Pfizer Cancer Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer Cancer Treatment Drugs Product Portfolio
  42. 8.7.5 Pfizer Recent Developments
  43. 8.8 Takeda
  44. 8.8.1 Takeda Company Information
  45. 8.8.2 Takeda Business Overview
  46. 8.8.3 Takeda Cancer Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Takeda Cancer Treatment Drugs Product Portfolio
  48. 8.8.5 Takeda Recent Developments
  49. 8.9 Eli Lilly
  50. 8.9.1 Eli Lilly Company Information
  51. 8.9.2 Eli Lilly Business Overview
  52. 8.9.3 Eli Lilly Cancer Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Eli Lilly Cancer Treatment Drugs Product Portfolio
  54. 8.9.5 Eli Lilly Recent Developments
  55. 8.10 AstraZeneca
  56. 8.10.1 AstraZeneca Company Information
  57. 8.10.2 AstraZeneca Business Overview
  58. 8.10.3 AstraZeneca Cancer Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 AstraZeneca Cancer Treatment Drugs Product Portfolio
  60. 8.10.5 AstraZeneca Recent Developments
  61. 8.11 Astellas
  62. 8.11.1 Astellas Company Information
  63. 8.11.2 Astellas Business Overview
  64. 8.11.3 Astellas Cancer Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Astellas Cancer Treatment Drugs Product Portfolio
  66. 8.11.5 Astellas Recent Developments
  67. 8.12 Merck & Co.
  68. 8.12.1 Merck & Co. Company Information
  69. 8.12.2 Merck & Co. Business Overview
  70. 8.12.3 Merck & Co. Cancer Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Merck & Co. Cancer Treatment Drugs Product Portfolio
  72. 8.12.5 Merck & Co. Recent Developments
  73. 8.13 Sanofi
  74. 8.13.1 Sanofi Company Information
  75. 8.13.2 Sanofi Business Overview
  76. 8.13.3 Sanofi Cancer Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Sanofi Cancer Treatment Drugs Product Portfolio
  78. 8.13.5 Sanofi Recent Developments
  79. 8.14 Bayer
  80. 8.14.1 Bayer Company Information
  81. 8.14.2 Bayer Business Overview
  82. 8.14.3 Bayer Cancer Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Bayer Cancer Treatment Drugs Product Portfolio
  84. 8.14.5 Bayer Recent Developments
  85. 8.15 Biogen Idec
  86. 8.15.1 Biogen Idec Company Information
  87. 8.15.2 Biogen Idec Business Overview
  88. 8.15.3 Biogen Idec Cancer Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Biogen Idec Cancer Treatment Drugs Product Portfolio
  90. 8.15.5 Biogen Idec Recent Developments
  91. 8.16 Eisai
  92. 8.16.1 Eisai Company Information
  93. 8.16.2 Eisai Business Overview
  94. 8.16.3 Eisai Cancer Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Eisai Cancer Treatment Drugs Product Portfolio
  96. 8.16.5 Eisai Recent Developments
  97. 8.17 Teva
  98. 8.17.1 Teva Company Information
  99. 8.17.2 Teva Business Overview
  100. 8.17.3 Teva Cancer Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Teva Cancer Treatment Drugs Product Portfolio
  102. 8.17.5 Teva Recent Developments
  103. 8.18 Otsuka
  104. 8.18.1 Otsuka Company Information
  105. 8.18.2 Otsuka Business Overview
  106. 8.18.3 Otsuka Cancer Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Otsuka Cancer Treatment Drugs Product Portfolio
  108. 8.18.5 Otsuka Recent Developments
  109. 8.19 Merck KGaA
  110. 8.19.1 Merck KGaA Company Information
  111. 8.19.2 Merck KGaA Business Overview
  112. 8.19.3 Merck KGaA Cancer Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Merck KGaA Cancer Treatment Drugs Product Portfolio
  114. 8.19.5 Merck KGaA Recent Developments
  115. 8.20 Ipsen
  116. 8.20.1 Ipsen Company Information
  117. 8.20.2 Ipsen Business Overview
  118. 8.20.3 Ipsen Cancer Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Ipsen Cancer Treatment Drugs Product Portfolio
  120. 8.20.5 Ipsen Recent Developments
  121. 8.21 AbbVie
  122. 8.21.1 AbbVie Company Information
  123. 8.21.2 AbbVie Business Overview
  124. 8.21.3 AbbVie Cancer Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 AbbVie Cancer Treatment Drugs Product Portfolio
  126. 8.21.5 AbbVie Recent Developments
  127. 8.22 Gilead Sciences
  128. 8.22.1 Gilead Sciences Company Information
  129. 8.22.2 Gilead Sciences Business Overview
  130. 8.22.3 Gilead Sciences Cancer Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Gilead Sciences Cancer Treatment Drugs Product Portfolio
  132. 8.22.5 Gilead Sciences Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cancer Treatment Drugs Value Chain Analysis
  2. 9.1.1 Cancer Treatment Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cancer Treatment Drugs Production Mode & Process
  6. 9.2 Cancer Treatment Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cancer Treatment Drugs Distributors
  9. 9.2.3 Cancer Treatment Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst